Stocks / NASDAQ / Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc

Our Opinion

Aurinia Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and clinical research.

Evidence:
http://investedmontonregion.com/health-sciences/

Company Description

Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The Company is currently developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), in an inflammation of the kidney caused by Systemic Lupus Erythematosus (SLE) and represents a serious progression of SLE. The Company is headquartered in Victoria, BC and focuses its development efforts globally.

Company website: http://www.auriniapharma.com